Brian Lortie
-

Blackstone Life Sciences Commits Up To $300 Million to Malvern-Based Uniquity Bio
Malvern-based Uniquity Bio is emerging from stealth mode after getting up to $300 million from Massachusetts-based private equity firm Blackstone Life Sciences, writes John George…












































